Ember LifeSciences: Valuation, Funding & Investors
Ember LifeSciences is a leading provider of revolutionary cold chain technology, leveraging proprietary temperature control technology to improve the transportation of life-saving medicines and vaccines globally. Initially launched as an offshoot of Ember Technologies, the company aims to redefine global medicine distribution through innovative solutions.
Leadership & Board
- Current Number of Employees
- 28
- Current LinkedIn Followers
- 1,482
Latest Estimated Valuation
- Total Amount Raised
- $44M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $27M
- Latest Funding Round
- Series A
Company Momentum Positive
Ember LifeSciences LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Ember LifeSciences had 28 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Ember LifeSciences had 1,482 followers as of October 26, 2026. The number of followers increased by 39 (2.70%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| May 27, 2026 | Series A | $27.00M | ― |
| Dec 16, 2025 | Series A | $16.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Amgen Ventures | Series A |
| TDF Ventures | Series A |
| Sea Court Capital | Series A |
| Cardinal Health | Series A |
| Carrier Ventures | Series A |
| Mike Pompeo | Series A |
Similar Companies
A snapshot of private companies similar to Ember LifeSciences, helping you discover and navigate related company profiles.
Related News and Analysis
